| Andrew C Lin, MD | |
|
415 S 28th Ave, Hattiesburg, MS 39401-7246 | |
| (601) 579-5444 | |
| (601) 579-5390 |
| Full Name | Andrew C Lin |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 45 Years |
| Location | 415 S 28th Ave, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528172244 | NPI | - | NPPES |
| 2290946 | Other | MS | AMERICAN ADMIN GROUP |
| 00118294 | Medicaid | MS | |
| 1419982 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 70873 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Home Care | Hattiesburg, MS | Home health agency |
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Merit Health Wesley | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hattiesburg Clinic, Pa | 5193706794 | 489 |
| Wesley Physician Services Llc | 2466559851 | 40 |
News Archive
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
Researchers including members from the Niels Bohr Institute at the University of Copenhagen have developed a new method for making detailed X-ray images of brain cells.
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%.
A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.
› Verified 5 days ago
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
Researchers including members from the Niels Bohr Institute at the University of Copenhagen have developed a new method for making detailed X-ray images of brain cells.
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%.
A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.
› Verified 5 days ago
| Entity Name | Wesley Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538200209 PECOS PAC ID: 2466559851 Enrollment ID: O20070518000496 |
News Archive
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
Researchers including members from the Niels Bohr Institute at the University of Copenhagen have developed a new method for making detailed X-ray images of brain cells.
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%.
A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew C Lin, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 579-5444 | Andrew C Lin, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 579-5444 |
News Archive
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
Researchers including members from the Niels Bohr Institute at the University of Copenhagen have developed a new method for making detailed X-ray images of brain cells.
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%.
A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.
› Verified 5 days ago
Laurie Evans Douglas, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-261-1700 Fax: 601-288-8290 | |
Dr. Charles Ramsey Mccollum Iii, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5650 Fax: 601-579-5212 | |
Porter Hudson Glover, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5680 Fax: 601-268-5778 | |
Alex Gauthier, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5001 Hardy St, Hattiesburg, MS 39402 Phone: 601-268-8000 | |
Grettel Rodriguez Garcia, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 31 Woodstone Dr, Hattiesburg, MS 39402 Phone: 347-342-2441 | |
Ms. Manal Mohammad Abdur Rahman, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7 Medical Blvd, Hattiesburg, MS 39401 Phone: 601-296-2990 Fax: 601-296-2860 | |
Dr. Vashishtha Patel, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 5001 Hardy St, Hattiesburg, MS 39402 Phone: 704-733-7499 |